Vyne Therapeutics
Price & Volume
Stats
See more52W Range | $0.28-$1.99 |
Market Cap | $20.3M |
Shares Short | 121,535 |
Financials
See moreRevenue (12 Mos) | $570,000 |
Revenue Growth (YoY) | 54.8% |
Gross Profit (12 Mos) | $570,000 |
Diluted EPS | -$0.63 |
News
See moreYahoo Finance • 4 months ago
BC-Most Active Stocks
Yahoo Finance • 5 months ago
VYNE Therapeutics GAAP EPS of -$0.17 misses by $0.04, revenue of $0.2M beats by $0.1M
Yahoo Finance • 8 months ago
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Yahoo Finance • 8 months ago
The trading volume of these stocks is deviating from the norm in today's session.
About
CEO | Mr. David T. Domzalski |
CFO | Mr. Tyler Zeronda CPA |
Address | P.O. BOX 125, Stewartsville, NJ, United States, 08886 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |
